Establish a regular eating schedule within a consistent window each day, ideally 12 hours
Companies are not allowed to use Section 503A to produce drugs that are essentially copies of a commercially available drug product. However, the FDA has interpreted commercially available to exclude drugs that are on the shortage list
But women, who have higher rates of GLP-1 treatment use than men, may at be at heightened risk of bone weakening during menopause, when bone loss naturally accelerates
The prescribing note should include: the patient's current HbA1c or BMI with date of measurement, a chronological list of all prior therapies with dates and reasons for discontinuation, a statement of why liraglutide specifically is preferred over other non-preferred agents (for example, the cardiovascular outcome benefit documented in LEADER [5] for a patient with known coronary artery disease), and a direct reference to the applicable ADA or Endocrine Society guideline recommendation [6][8]
PlexusDx prescribers screen for contraindications and monitor your health throughout treatment